Cliff Asness's RIGL Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 91,008 shares of Rigel Pharmaceuticals, Inc. (RIGL) worth $2.46 M, representing 0.00% of the portfolio. First purchased in 2025-Q1, this short-term holding has been held for 5 quarters.
Based on 13F filings, Cliff Asness has maintained this position in RIGL for several quarters, showing initial confidence in the investment. Largest addition occurred in Q4 2025, adding 53,135 shares. Largest reduction occurred in Q1 2026, reducing 18,728 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Rigel Pharmaceuticals (RIGL) Holding Value Over Time
Track share changes against reported price movement
Quarterly Rigel Pharmaceuticals (RIGL) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -18,728 | Reduce 17.07% | 91,008 | $27.04 |
| Q4 2025 | +53,135 | Add 93.88% | 109,736 | $42.83 |
| Q3 2025 | +46,563 | Add 463.87% | 56,601 | $28.33 |
| Q2 2025 | -588 | Reduce 5.53% | 10,038 | $18.73 |
| Q1 2025 | +10,626 | New Buy | 10,626 | $17.99 |
Cliff Asness's Rigel Pharmaceuticals Investment FAQs
Cliff Asness first purchased Rigel Pharmaceuticals, Inc. (RIGL) in Q1 2025, acquiring 10,626 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Rigel Pharmaceuticals, Inc. (RIGL) for 5 quarters since Q1 2025.
Cliff Asness's largest addition to Rigel Pharmaceuticals, Inc. (RIGL) was in Q4 2025, adding 109,736 shares worth $4.7 M.
According to the latest 13F filing for Q1 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 91,008 shares of Rigel Pharmaceuticals, Inc. (RIGL), valued at approximately $2.46 M.
As of the Q1 2026 filing, Rigel Pharmaceuticals, Inc. (RIGL) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Rigel Pharmaceuticals, Inc. (RIGL) was 109,736 shares, as reported at the end of Q4 2025.